Stallergenes Greer Appoints Andreas Amrein As Chief Executive Officer

Mar 04, 2025•4 months ago

Position

Chief Executive Officer

Company

Stallergenes Greer

Andreas Amrein

BaarBiotechnologyHealth Care

Description

Stallergenes Greer's Board of Directors has appointed Andreas Amrein as Chief Executive Officer with effect from April 1, 2025. After more than 10 years with the company, Michele Antonelli will step down from his role as Chief Executive Officer at the end of March 2025.

Company Information

Company

Stallergenes Greer

Location

Baar, Zug, Switzerland

About

Stallergenes Greer is a global biopharmaceutical company specialising in allergy therapeutics through the research, development and commercialisation of allergen immunotherapy products and services. Supported by more than 100 years of expertise and innovation, our products are available for patients in over 40 countries. Our purpose is to enable precision medicine to improve life for people with allergies. With more than 1,100 employees worldwide and manufacturing facilities in both Europe and the United States, Stallergenes Greer is driving a continuing leadership in allergy immunotherapy.

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Related People

Andreas hidden